Miao Hu, Ph.D. - Publications

Affiliations: 
2010 The Chinese University of Hong Kong, Hong Kong, Hong Kong 
Area:
Medicine and Surgery, Pharmacology

114 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Pang J, Chan DC, Hu M, Muir LA, Kwok S, Charng MJ, Florkowski CM, George PM, Lin J, Loi DD, Marais AD, Nawawi HM, Gonzalez-Santos LE, Su TC, Truong TH, et al. Comparative aspects of the care of familial hypercholesterolemia in the "Ten Countries Study". Journal of Clinical Lipidology. PMID 30797720 DOI: 10.1016/j.jacl.2019.01.009  1
2019 Tomlinson B, Hu M, Chow E. Current status of familial hypercholesterolemia in Chinese populations. Current Opinion in Lipidology. PMID 30649024 DOI: 10.1097/MOL.0000000000000580  1
2018 Ma W, Xie F, Zhang S, Wang H, Hu M, Sun Y, Zhong M, Zhu J, Qi B, Li Y. Characterizing the Structural and Functional Properties of Soybean Protein Extracted from Full-Fat Soybean Flakes after Low-Temperature Dry Extrusion. Molecules (Basel, Switzerland). 23. PMID 30544764 DOI: 10.3390/molecules23123265  0.52
2018 Hagger MS, Hardcastle SJ, Hu M, Kwok S, Lin J, Nawawi HM, Pang J, Santos RD, Soran H, Su TC, Tomlinson B, Watts GF. Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia. Atherosclerosis. 277: 493-501. PMID 30270090 DOI: 10.1016/j.atherosclerosis.2018.06.010  1
2018 Li C, Belkin D, Li Y, Yan P, Hu M, Ge N, Jiang H, Montgomery E, Lin P, Wang Z, Song W, Strachan JP, Barnell M, Wu Q, Williams RS, et al. Efficient and self-adaptive in-situ learning in multilayer memristor neural networks. Nature Communications. 9: 2385. PMID 29921923 DOI: 10.1038/s41467-018-04484-2  0.52
2018 Hagger MS, Hardcastle SJ, Hu M, Kwok S, Lin J, Nawawi HM, Pang J, Santos RD, Soran H, Su TC, Tomlinson B, Watts GF. Health literacy in familial hypercholesterolemia: A cross-national study. European Journal of Preventive Cardiology. 2047487318766954. PMID 29592531 DOI: 10.1177/2047487318766954  1
2018 Hu M, Graves CE, Li C, Li Y, Ge N, Montgomery E, Davila N, Jiang H, Williams RS, Yang JJ, Xia Q, Strachan JP. Memristor-Based Analog Computation and Neural Network Classification with a Dot Product Engine. Advanced Materials (Deerfield Beach, Fla.). PMID 29318659 DOI: 10.1002/adma.201705914  0.52
2017 Tomlinson B, Hu M, Chan J, Mcintyre A, Hegele R. Severe familial hypercholesterolaemia in two brothers with three heterozygous coding mutations in LDLR. Atherosclerosis. 263: e230. PMID 29365890 DOI: 10.1016/j.atherosclerosis.2017.06.749  1
2017 Tomlinson B, Hu M, Chan J, Mcintyre A, Hegele R. Severe hypertriglycerideamia related to a novel mutation in TRIB1 and a known variant in APOA5. Atherosclerosis. 263: e230. PMID 29365889 DOI: 10.1016/j.atherosclerosis.2017.06.748  1
2017 Pang J, Hu M, Lin J, Miida T, Nawawi HM, Park JE, Wu X, Ramli AS, Kim NT, Kwok S, Gonzalez-Santos LE, Su TC, Truong TH, Soran H, Yamashita S, et al. An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study". Bmj Open. 7: e017817. PMID 29074516 DOI: 10.1136/bmjopen-2017-017817  1
2017 Griffith JF, Hu M, Yeung DKW, Guo P, Lam SL, Xiao F, Wang D, Tomlinson B. Achilles Tendon Xanthomas: Fat-Water Separation at Baseline and After Treatment. Radiology. 161435. PMID 28825891 DOI: 10.1148/radiol.2017161435  1
2017 Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. Evolocumab for the treatment of hypercholesterolemia. Expert Opinion On Biological Therapy. 1-15. PMID 28812389 DOI: 10.1080/14712598.2017.1365134  1
2017 Peng J, Gao Y, Zhu C, Liu B, Gao Y, Hu M, Wu W, Jiang H. Synthesis of Polysubstituted 3-Amino Pyrroles via Palladium-Catalyzed Multicomponent Reaction (MCR). The Journal of Organic Chemistry. PMID 28303718 DOI: 10.1021/acs.joc.7b00098  0.32
2017 Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. Alirocumab for the treatment of hypercholesterolaemia. Expert Opinion On Biological Therapy. PMID 28277798 DOI: 10.1080/14712598.2017.1305354  1
2017 Zhang Z, Zhu Q, Hu M, Gao Z, An F, Li M, Jiang Y. Low-temperature conditioning induces chilling tolerance in stored mango fruit Food Chemistry. 219: 76-84. DOI: 10.1016/j.foodchem.2016.09.123  0.32
2017 Zhang K, Ding Y, Zhu M, Hu M, Wang S, Xiao Y. Calculating vibrational mode contributions to sound absorption in excitable gas mixtures by decomposing multi-relaxation absorption spectroscopy Applied Acoustics. 116: 195-204. DOI: 10.1016/j.apacoust.2016.09.025  1
2016 Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. Liraglutide for weight management: benefits and risks. Current Medical Research and Opinion. 1-9. PMID 27936966 DOI: 10.1080/03007995.2016.1271315  1
2016 Peng J, Gao Y, Hu W, Gao Y, Hu M, Wu W, Ren Y, Jiang H. Palladium-Catalyzed Multicomponent Reaction (MCR) of Propargylic Carbonates with Isocyanides. Organic Letters. 18: 5924-5927. PMID 27934484 DOI: 10.1021/acs.orglett.6b02999  0.32
2016 Hu M, Zhang Y, Wei M, Zeng R, Li Q, Lu Y, Wei Y. Microchip dual-frequency laser with well-balanced intensity utilizing temperature control. Optics Express. 24: 23383-23389. PMID 27828401  0.36
2016 Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. Evaluation of the pharmacokinetics, pharmacodynamics and clinical efficacy of empagliflozin for the treatment of type 2 diabetes. Expert Opinion On Drug Metabolism & Toxicology. PMID 27817207 DOI: 10.1080/17425255.2017.1258401  1
2016 Zeng W, Chu T, Hu M, Kong A, Tomlinson B. OS 31-02 ANTIHYPERTENSIVE RESPONSE TO BISOPROLOL WAS NOT RELATED TO POLYMORPHISMS IN ADRB1 Or CYP2D6 IN CHINESE HYPERTENSIVE PATIENTS. Journal of Hypertension. 34: e388. PMID 27754210 DOI: 10.1097/01.hjh.0000500990.24186.18  1
2016 Li S, Liu W, Li Y, Zhao S, Liu C, Hu M, Yue W, Liu Y, Wang Y, Yang R, Xiang R, Liu F. Contribution of secondary Igkappa rearrangement to primary immunoglobulin repertoire diversification. Molecular Immunology. 78: 193-206. PMID 27665270 DOI: 10.1016/j.molimm.2016.09.006  0.52
2016 Hu M, Lee HK, To KK, Fok BS, Wo SK, Ho CS, Wong CK, Zuo Z, Chan TY, Chan JC, Tomlinson B. Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin. European Journal of Clinical Pharmacology. PMID 27651239 DOI: 10.1007/s00228-016-2130-1  1
2016 Zeng W, Chu T, Hu M, Kong A, Tomlinson B. OS 31-02 ANTIHYPERTENSIVE RESPONSE TO BISOPROLOL WAS NOT RELATED TO POLYMORPHISMS IN ADRB1 Or CYP2D6 IN CHINESE HYPERTENSIVE PATIENTS. Journal of Hypertension. 34: e388. PMID 27643167 DOI: 10.1097/01.hjh.0000500990.24186.18  1
2016 Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes. Expert Opinion On Drug Metabolism & Toxicology. PMID 27607315 DOI: 10.1080/17425255.2016.1234608  0.48
2016 Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. Investigational glucagon-like peptide-1 agonists for the treatment of obesity. Expert Opinion On Investigational Drugs. 1-13. PMID 27563838 DOI: 10.1080/13543784.2016.1221925  0.48
2016 Chan SW, Xiao Y, Hu M, Yin OQ, Chu TT, Fok BS, Lee VH, Tomlinson B. Associations of the CYP3A5*3 and CYP3A4*1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6β-hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male Chinese. Journal of Clinical Pharmacy and Therapeutics. PMID 27511886 DOI: 10.1111/jcpt.12433  1
2016 Zheng L, Zhu L, Zhao M, Shi J, Li Y, Yu J, Jiang H, Wu J, Tong Y, Liu Y, Hu M, Lu L, Liu Z. In Vivo Exposure of Kaempferol Is Driven by Phase II Metabolic Enzymes and Efflux Transporters. The Aaps Journal. PMID 27393480 DOI: 10.1208/s12248-016-9951-9  0.52
2016 Watts GF, Ding PY, George P, Hagger MS, Hu M, Lin J, Khoo KL, Marais AD, Miida T, Nawawi HM, Pang J, Park JE, Gonzalez-Santos LB, Su TC, Truong TH, et al. Translational Research for Improving the Care of Familial Hypercholesterolemia: The "Ten Countries Study" and Beyond. Journal of Atherosclerosis and Thrombosis. PMID 27384016 DOI: 10.5551/jat.35949  0.48
2016 Hu M, Zong X, Zheng J, Mann JJ, Li Z, Pantazatos SP, Li Y, Liao Y, He Y, Zhou J, Sang D, Zhao H, Tang J, Chen H, Lv L, et al. Risperidone-induced topological alterations of anatomical brain network in first-episode drug-naive schizophrenia patients: a longitudinal diffusion tensor imaging study. Psychological Medicine. 1-12. PMID 27338296 DOI: 10.1017/S0033291716001380  0.52
2016 Ke C, Yang X, Rao H, Zeng W, Hu M, Tao Y, Huang J. Whole-cell conversion of l-glutamic acid into gamma-aminobutyric acid by metabolically engineered Escherichia coli. Springerplus. 5: 591. PMID 27247887 DOI: 10.1186/s40064-016-2217-2  0.52
2016 Gao Y, Gao Y, Tang X, Peng J, Hu M, Wu W, Jiang H. Copper-Catalyzed Oxysulfenylation of Enolates with Sodium Sulfinates: A Strategy To Construct Sulfenylated Cyclic Ethers. Organic Letters. PMID 26914291 DOI: 10.1021/acs.orglett.6b00272  0.32
2016 Tomlinson B, Hu M, Zhang Y, Liu ZM, Chan P. Response to the letter "No evidence to support high-intensity statin in Chinese patients with coronary heart disease". International Journal of Cardiology. 209: 192-193. PMID 26896621 DOI: 10.1016/j.ijcard.2016.02.047  1
2016 Hu M, Hooper AJ, Bockxmeer FM, Watts GF, Chan JC, Tomlinson B. Management of Familial Hypercholesterolemia in Hong Kong. Journal of Atherosclerosis and Thrombosis. PMID 26875521 DOI: 10.5551/jat.34314  1
2016 Quennehen B, Raut JC, Law KS, Daskalakis N, Ancellet G, Clerbaux C, Kim SW, Lund MT, Myhre G, Olivié DJL, Safieddine S, Skeie RB, Thomas JL, Tsyro S, Bazureau A, ... ... Hu M, et al. Multi-model evaluation of short-lived pollutant distributions over east Asia during summer 2008 Atmospheric Chemistry and Physics. 16: 10765-10792. DOI: 10.5194/acp-16-10765-2016  0.32
2016 Ren F, Li Y, Hu M, Xu L. Face recognition method based on multi features description and local fusion classification decision Guangdian Gongcheng/Opto-Electronic Engineering. 43: 1-8. DOI: 10.3969/j.issn.1003-501X.2016.09.001  0.52
2016 He X, Wang X, Li M, Hu M, Liu J, Qiu Q. Research review on mid-infrared liquid crystal optical phased array Hongwai Yu Jiguang Gongcheng/Infrared and Laser Engineering. 45. DOI: 10.3788/IRLA201645.0830003  0.32
2016 Hu M, Yang Y, Ji Z, Luo J. RBM15 functions in blood diseases Current Cancer Drug Targets. 16: 579-585. DOI: 10.2174/1568009616666160112105706  0.4
2016 Shao M, Jiang J, Li M, Wu L, Hu M. Recent developments in the analysis of polybrominated diphenyl ethers and polybrominated biphenyls in plastic Reviews in Analytical Chemistry. 35: 133-143. DOI: 10.1515/revac-2016-0012  0.32
2016 Li Z, Liu Y, Hu M, Zhang Y, Wu R. Damage fffect evaluation of God stick space-based kinetic energy weapons Zhendong Yu Chongji/Journal of Vibration and Shock. 35. DOI: 10.13465/j.cnki.jvs.2016.14.026  0.36
2016 Su C, Wu Z, Lü Z, Yang Y, Dou X, Hu M. Distributed secondary power optimization control for islanded microgrid Dianwang Jishu/Power System Technology. 40: 2689-2697. DOI: 10.13335/j.1000-3673.pst.2016.09.016  0.4
2016 Xing J, Shao L, Zhang W, Peng J, Wang W, Guo Q, Hu M, Shuai S. Individual particles types and characteristics of PM2.5 from gasoline vehicle emission Zhongguo Dianji Gongcheng Xuebao/Proceedings of the Chinese Society of Electrical Engineering. 36: 4459-4465. DOI: 10.13334/j.0258-8013.pcsee.160639  0.32
2016 Sun X, Hu M, Guo S, Huang X. Application naturally occurred radiocarbon (14C) in source apportionment of atmospheric particulate matter Zhongguo Dianji Gongcheng Xuebao/Proceedings of the Chinese Society of Electrical Engineering. 36: 4436-4442. DOI: 10.13334/j.0258-8013.pcsee.160377  0.32
2016 Xiao Y, Hu M, Li M, Qin Y, Peng J, Zhang W, Zheng J, Du Z, Deng L, Shuai S. Stable isotopic characteristics of CO2 emitted by gasoline vehicles Zhongguo Dianji Gongcheng Xuebao/Proceedings of the Chinese Society of Electrical Engineering. 36: 4497-4504. DOI: 10.13334/j.0258-8013.pcsee.160372  0.32
2016 Hu M, Wang X, Luo J, Qi S, Li Y, Zhang Q. Study of emission properties and evaporation rate of impregnated tungstate cathode 2016 Ieee International Vacuum Electronics Conference, Ivec 2016. DOI: 10.1109/IVEC.2016.7561928  0.52
2016 Qi S, Wang X, Luo J, Hu M, Zhao Q, Li Y, Zhang Q. Study on a novel Y2O3-Gd2O3-HfO2 impregnated W base direct-heated cathode 2016 Ieee International Vacuum Electronics Conference, Ivec 2016. DOI: 10.1109/IVEC.2016.7561922  0.52
2016 Duan H, Zhang H, Huang Q, Zhang Y, Hu M, Niu Y, Zhu J. Characterization and environmental impact analysis of sea land reclamation activities in China Ocean and Coastal Management. 130: 128-137. DOI: 10.1016/j.ocecoaman.2016.06.006  0.36
2016 Wang J, Tao L, Zhao H, Hu M, Zheng X, Peng H, Gan X, Xiao W, Cao P, Qin W, Qiu G, Wang D. Cooperative effect of chalcopyrite and bornite interactions during bioleaching by mixed moderately thermophilic culture Minerals Engineering. 95: 116-123. DOI: 10.1016/j.mineng.2016.06.006  0.32
2016 Yan W, Hu M, Liang J, Wang D, Wei Y, Zhang W, Qin Y. Preparation and room temperature NO2-sensing performances of n-porous silicon/n-WO3 nanowires heterojunction Materials Research Bulletin. 83: 453-458. DOI: 10.1016/j.materresbull.2016.06.040  0.32
2016 Liu X, Hu M, Wang Y, Liu J, Qin Y. High sensitivity NO2 sensor based on CuO/p-porous silicon heterojunction at room temperature Journal of Alloys and Compounds. 685: 364-369. DOI: 10.1016/j.jallcom.2016.05.215  0.32
2016 Zhang W, Hu M, Liu X, Wei Y, Li N, Qin Y. Synthesis of the cactus-like silicon nanowires/tungsten oxide nanowires composite for room-temperature NO2 gas sensor Journal of Alloys and Compounds. 679: 391-399. DOI: 10.1016/j.jallcom.2016.03.287  0.32
2016 Kulmama M, Petäjä T, Kerminen VM, Kujansuu J, Ruuskanen T, Ding A, Nie W, Hu M, Wang Z, Wu Z, Wang L, Worsnop DR. On secondary new particle formation in China Frontiers of Environmental Science and Engineering. 10. DOI: 10.1007/s11783-016-0850-1  0.32
2016 Kuang Y, Zhao CS, Ma N, Liu HJ, Bian YX, Tao JC, Hu M. Deliquescent phenomena of ambient aerosols on the North China Plain Geophysical Research Letters. 43: 8744-8750. DOI: 10.1002/2016GL070273  0.32
2016 Gu FT, Hu M, Wang Y, Li MR, Guo QF, Wu ZJ. Characteristics of PM2.5 pollutionin winter and spring of Beijing during 2009~2010 Zhongguo Huanjing Kexue/China Environmental Science. 36: 2578-2584.  0.32
2015 Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. An overview of novel GLP-1 receptor agonists for type II diabetes. Expert Opinion On Investigational Drugs. PMID 26587691 DOI: 10.1517/13543784.2016.1123249  1
2015 Hu M, Fok BS, Wo SK, Lee VH, Zuo Z, Tomlinson B. Effect of common polymorphisms of the farnesoid X receptor and bile acid transporters on the pharmacokinetics of ursodeoxycholic acid. Clinical and Experimental Pharmacology & Physiology. PMID 26382575 DOI: 10.1111/1440-1681.12490  0.48
2015 Ding C, Hu M, Wu YJ, Tomlinson B. Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia. Lipids in Health and Disease. 14: 107. PMID 26365713 DOI: 10.1186/s12944-015-0116-0  1
2015 Wang D, Shi L, Chu WC, Hu M, Tomlinson B, Huang WH, Wang T, Heng PA, Yeung DK, Ahuja AT. Fully automatic and nonparametric quantification of adipose tissue in fat-water separation MR imaging. Medical & Biological Engineering & Computing. PMID 26245254 DOI: 10.1007/s11517-015-1347-y  1
2015 Hu M, Yang YL, Chan P, Tomlinson B. Pharmacogenetics of cutaneous flushing response to niacin/laropiprant combination in Hong Kong Chinese patients with dyslipidemia. Pharmacogenomics. 16: 1387-97. PMID 26226939 DOI: 10.2217/pgs.15.79  1
2015 Zhang Y, Hu M, Li P, Wang X, Meng Q. Analysis of trichloroethylene removal and bacterial community function based on pH-adjusted in an upflow anaerobic sludge blanket reactor. Applied Microbiology and Biotechnology. PMID 26189017 DOI: 10.1007/s00253-015-6800-1  0.36
2015 Hu M, Yang YL, Masuda D, Yamashita S, Tomlinson B. Effect of Extended-Release Niacin/Laropiprant Combination on Plasma Adiponectin and Insulin Resistance in Chinese Patients with Dyslipidaemia. Disease Markers. 2015: 154014. PMID 26063948 DOI: 10.1155/2015/154014  1
2015 Hu M, Yang YL, Ng CF, Lee CP, Lee VW, Hanada H, Masuda D, Yamashita S, Tomlinson B. Effects of phenotypic and genotypic factors on the lipid responses to niacin in chinese patients with dyslipidemia. Medicine. 94: e881. PMID 25997070 DOI: 10.1097/MD.0000000000000881  1
2015 Zhang Y, Hu M, Li P, Wang X, Meng Q. Trichloroethylene removal and bacterial variations in the up-flow anaerobic sludge blanket reactor in response to temperature shifts. Applied Microbiology and Biotechnology. 99: 6091-102. PMID 25728444 DOI: 10.1007/s00253-015-6480-x  0.36
2015 Liu ZM, Hu M, Chan P, Tomlinson B. Early investigational drugs targeting PPAR-α for the treatment of metabolic disease. Expert Opinion On Investigational Drugs. 24: 611-21. PMID 25604802 DOI: 10.1517/13543784.2015.1006359  1
2015 Zhang Y, Wang X, Hu M, Li P. Effect of hydraulic retention time (HRT) on the biodegradation of trichloroethylene wastewater and anaerobic bacterial community in the UASB reactor. Applied Microbiology and Biotechnology. 99: 1977-87. PMID 25277413 DOI: 10.1007/s00253-014-6096-6  0.36
2014 Hu M, Tomlinson B. Niacin for reduction of cardiovascular risk. The New England Journal of Medicine. 371: 1941-2. PMID 25390751 DOI: 10.1056/NEJMc1411240#SA3  1
2014 Xiao YJ, Hu M, Tomlinson B. Effects of grapefruit juice on cortisol metabolism in healthy male Chinese subjects. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 74: 85-90. PMID 25265455 DOI: 10.1016/j.fct.2014.09.012  1
2014 To KK, Hu M, Tomlinson B. Expression and activity of ABCG2, but not ABCB1 or OATP1B1, are associated with cholesterol levels: evidence from in vitro and in vivo experiments. Pharmacogenomics. 15: 1091-104. PMID 25084202 DOI: 10.2217/pgs.14.58  1
2014 Hu M, Yuen YP, Kwok JS, Griffith JF, Tomlinson B. Potential effects of NPC1L1 polymorphisms in protecting against clinical disease in a chinese family with sitosterolaemia. Journal of Atherosclerosis and Thrombosis. 21: 989-95. PMID 25056759 DOI: DN/JST.JSTAGE/jat/24679  1
2014 Hu M, Tomlinson B. Ezetimibe treatment should be considered for patients with sitosterolemia. Pediatric Nephrology (Berlin, Germany). 29: 1469-70. PMID 24839218 DOI: 10.1007/s00467-014-2843-2  1
2014 Hu M, Zeng W, Tomlinson B. Evaluation of a crataegus-based multiherb formula for dyslipidemia: a randomized, double-blind, placebo-controlled clinical trial. Evidence-Based Complementary and Alternative Medicine : Ecam. 2014: 365742. PMID 24834096 DOI: 10.1155/2014/365742  1
2014 Zhang Y, Sun G, Wang X, Wang L, Hu M, Wang Z, Tao Y. Efforts on membrane properties and enzymes by adding divalent cations and sodium carboxymethyl cellulose. Carbohydrate Polymers. 106: 94-100. PMID 24721055 DOI: 10.1016/j.carbpol.2014.02.011  0.36
2014 Zhang Y, Liu Y, Hu M, Jiang Z. Acclimation of the trichloroethylene-degrading anaerobic granular sludge and the degradation characteristics in an upflow anaerobic sludge blanket reactor. Water Science and Technology : a Journal of the International Association On Water Pollution Research. 69: 120-7. PMID 24434977 DOI: 10.2166/wst.2013.564  0.36
2014 Hu M, Tomlinson B. Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin. Expert Opinion On Drug Metabolism & Toxicology. 10: 51-65. PMID 24156555 DOI: 10.1517/17425255.2014.851667  1
2013 Yang YL, Hu M, Chang M, Tomlinson B. A high incidence of exanthematous eruption associated with niacin/laropiprant combination in Hong Kong Chinese patients. Journal of Clinical Pharmacy and Therapeutics. 38: 528-32. PMID 24020480 DOI: 10.1111/jcpt.12096  1
2013 Hu M, Tomlinson B. Lipid-lowing pharmacogenomics in Chinese patients. Expert Review of Cardiovascular Therapy. 11: 985-97. PMID 23952137 DOI: 10.1586/14779072.2013.814839  1
2013 Lee HK, Hu M, Lui SSh, Ho CS, Wong CK, Tomlinson B. Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients. Pharmacogenomics. 14: 1283-94. PMID 23930675 DOI: 10.2217/pgs.13.115  1
2013 Hu M, Tomlinson B. Pharmacogenomics of lipid-lowering therapies. Pharmacogenomics. 14: 981-95. PMID 23746191 DOI: 10.2217/pgs.13.71  1
2013 Lee HK, Ho CS, Hu M, Tomlinson B, Wong CK. Development and validation of a sensitive method for simultaneous determination of rosuvastatin and N-desmethyl rosuvastatin in human plasma using liquid chromatography/negative electrospray ionization/tandem mass spectrometry. Biomedical Chromatography : Bmc. 27: 1369-74. PMID 23722358 DOI: 10.1002/bmc.2944  1
2013 Hu M, Lui SS, Ko GT, Tomlinson B. Do the lipid responses to rosuvastatin and atorvastatin differ between Chinese and Caucasians? Comparison of the DISCOVERY-Hong Kong study with other DISCOVERY studies. International Journal of Cardiology. 168: 3071-3. PMID 23642826 DOI: 10.1016/j.ijcard.2013.04.091  1
2013 Hu M, Tomlinson B. Current Perspectives on rosuvastatin. Integrated Blood Pressure Control. 6: 15-25. PMID 23637557 DOI: 10.2147/IBPC.S34814  1
2013 Zhang Y, Dong X, Jiang Z, Cao B, Ge S, Hu M. Assessment of the ecological security of immobilized enzyme remediation process with biological indicators of soil health. Environmental Science and Pollution Research International. 20: 5773-80. PMID 23468306 DOI: 10.1007/s11356-012-1455-2  0.36
2013 Hu M, Mak VW, Xiao Y, Tomlinson B. Associations between the genotypes and phenotype of CYP3A and the lipid response to simvastatin in Chinese patients with hypercholesterolemia. Pharmacogenomics. 14: 25-34. PMID 23252946 DOI: 10.2217/pgs.12.181  1
2013 Liu J, Kong X, Wang L, Qi H, Di W, Zhang X, Wu L, Chen X, Yu J, Zha J, Lv S, Zhang A, Cheng P, Hu M, Li Y, et al. Essential roles of 11β-HSD1 in regulating brown adipocyte function. Journal of Molecular Endocrinology. 50: 103-13. PMID 23197361 DOI: 10.1530/JME-12-0099  0.52
2013 Chan SW, Hu M, Ko SS, Tam CW, Fok BS, Yin OQ, Chow MS, Tomlinson B. CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects. European Journal of Clinical Pharmacology. 69: 799-806. PMID 23090703 DOI: 10.1007/s00228-012-1428-x  1
2013 Hu M, Mak VW, Yin OQ, Chu TT, Tomlinson B. Effects of grapefruit juice and SLCO1B1 388A>G polymorphism on the pharmacokinetics of pitavastatin. Drug Metabolism and Pharmacokinetics. 28: 104-8. PMID 22850760 DOI: DN/JST.JSTAGE/dmpk/DMPK-12-RG-067  1
2013 Hu M, Lan W, Lam CW, Mak YT, Pang CP, Tomlinson B. Heterozygous familial hypercholesterolemia in Hong Kong Chinese. Study of 252 cases. International Journal of Cardiology. 167: 762-7. PMID 22464486 DOI: 10.1016/j.ijcard.2012.03.048  1
2012 Hu M, Cheung BM, Tomlinson B. Safety of statins: an update. Therapeutic Advances in Drug Safety. 3: 133-44. PMID 25083232 DOI: 10.1177/2042098612439884  1
2012 Hu M, Mak VW, Tomlinson B. Polymorphisms in apolipoprotein E and apolipoprotein A-V do not influence the lipid response to rosuvastatin but are associated with baseline lipid levels in Chinese patients with hyperlipidemia. Journal of Clinical Lipidology. 6: 585-92. PMID 23312054 DOI: 10.1016/j.jacl.2012.02.005  1
2012 Hu M, Fan L, Zhou HH, Tomlinson B. Theranostics meets traditional Chinese medicine: rational prediction of drug-herb interactions. Expert Review of Molecular Diagnostics. 12: 815-30. PMID 23249200 DOI: 10.1586/erm.12.126  1
2012 Hu M, Mak VW, Tomlinson B. Comments on "CYP3AP1*3 allele is associated with lipid-lowering efficacy of simvastatin and atorvastatin in Chinese women". Journal of Clinical Pharmacology. 52: 1768-9; author reply. PMID 23105125 DOI: 10.1177/0091270011415411  1
2012 Zhang Y, Cao B, Jiang Z, Dong X, Hu M, Wang Z. Metabolic ability and individual characteristics of an atrazine-degrading consortium DNC5. Journal of Hazardous Materials. 237: 376-81. PMID 22981745 DOI: 10.1016/j.jhazmat.2012.08.047  0.36
2012 Hu M, Tomlinson B. Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia. Atherosclerosis. 223: 427-32. PMID 22749334 DOI: 10.1016/j.atherosclerosis.2012.06.002  1
2012 Hu M, Yang YL, Fok BS, Chan SW, Chu TT, Poon EW, Yin OQ, Lee VH, Tomlinson B. Effects of CYP2D6*10, CYP3A5*3, CYP1A2*1F, and ABCB1 C3435T polymorphisms on the pharmacokinetics of flecainide in healthy Chinese subjects. Drug Metabolism and Drug Interactions. 27: 33-9. PMID 22718623 DOI: 10.1515/dmdi-2011-0032  1
2012 Hu M, Mak VW, Tomlinson B. Intronic variants in SLCO1B1 related to statin-induced myopathy are associated with the low-density lipoprotein cholesterol response to statins in Chinese patients with hyperlipidaemia. Pharmacogenetics and Genomics. 22: 803-6. PMID 22668755 DOI: 10.1097/FPC.0b013e3283557c98  1
2012 Chan SW, Hu M, Tomlinson B. The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure. Expert Opinion On Drug Metabolism & Toxicology. 8: 767-90. PMID 22621216 DOI: 10.1517/17425255.2012.685157  1
2012 Hu M, Lui SS, Tam LS, Li EK, Tomlinson B. The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin. Journal of Lipid Research. 53: 1384-9. PMID 22534644 DOI: 10.1194/jlr.M026054  1
2012 Hu M, Chu WC, Yamashita S, Yeung DK, Shi L, Wang D, Masuda D, Yang Y, Tomlinson B. Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patients. Journal of Lipid Research. 53: 802-9. PMID 22315393 DOI: 10.1194/jlr.P023614  1
2012 Yin OQ, Mak VW, Hu M, Fok BS, Chow MS, Tomlinson B. Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects. European Journal of Clinical Pharmacology. 68: 943-9. PMID 22281720 DOI: 10.1007/s00228-011-1202-5  1
2011 Zhang Y, Jiang Z, Cao B, Hu M, Wang Z, Dong X. Chemotaxis to atrazine and detection of a xenobiotic catabolic plasmid in Arthrobacter sp. DNS10. Environmental Science and Pollution Research International. 19: 2951-8. PMID 22351258 DOI: 10.1007/s11356-012-0805-4  0.36
2011 Yang Y, Chan SW, Hu M, Walden R, Tomlinson B. Effects of some common food constituents on cardiovascular disease. Isrn Cardiology. 2011: 397136. PMID 22347642 DOI: 10.5402/2011/397136  1
2011 Zhang Y, Hu M, Jiang Z, Liu Y. Effect of anthraquinone-2,6-disulfonate on the trichloroethene degradation by Dehalococcoides-containing consortium. Journal of Hazardous Materials. 192: 1896-9. PMID 21782334 DOI: 10.1016/j.jhazmat.2011.06.087  0.36
2011 Hu M, Zhang Y, Wang Z, Jiang Z, Li J. Influence of humic acid on the trichloroethene degradation by Dehalococcoides-containing consortium. Journal of Hazardous Materials. 190: 1074-8. PMID 21501929 DOI: 10.1016/j.jhazmat.2011.03.088  0.36
2011 Liu J, Wang L, Zhang A, Di W, Zhang X, Wu L, Yu J, Zha J, Lv S, Cheng P, Hu M, Li Y, Qi H, Ding G, Zhong Y. Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity. Endocrine Journal. 58: 199-209. PMID 21325744 DOI: JST.JSTAGE/endocrj/K10E-318  0.52
2011 Hu M, To KK, Mak VW, Tomlinson B. The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins. Expert Opinion On Drug Metabolism & Toxicology. 7: 49-62. PMID 21091277 DOI: 10.1517/17425255.2011.538383  1
2010 Lv S, Wu L, Cheng P, Yu J, Zhang A, Zha J, Liu J, Wang L, DI W, Hu M, Qi H, Li Y, Ding G. Correlation of obesity and osteoporosis: Effect of free fatty acids on bone marrow-derived mesenchymal stem cell differentiation. Experimental and Therapeutic Medicine. 1: 603-610. PMID 22993583 DOI: 10.3892/etm_00000095  0.52
2010 Hu M, Lee MH, Mak VW, Tomlinson B. Effect of central obesity, low high-density lipoprotein cholesterol and C-reactive protein polymorphisms on C-reactive protein levels during treatment with Rosuvastatin (10 mg Daily). The American Journal of Cardiology. 106: 1588-93. PMID 21094359 DOI: 10.1016/j.amjcard.2010.07.044  1
2010 Hu M, Tomlinson B. Growth hormone-releasing factor agonists for the treatment of HIV-associated lipodystrophy. Current Opinion in Investigational Drugs (London, England : 2000). 11: 1143-50. PMID 20872317  1
2010 Hu M, Tomlinson B. Pharmacokinetic evaluation of lanreotide. Expert Opinion On Drug Metabolism & Toxicology. 6: 1301-12. PMID 20716034 DOI: 10.1517/17425255.2010.513700  1
2010 Hu M, Lui SS, Mak VW, Chu TT, Lee VW, Poon EW, Tsui TK, Ko GT, Baum L, Tam LS, Li EK, Tomlinson B. Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients. Pharmacogenetics and Genomics. 20: 634-7. PMID 20679960 DOI: 10.1097/FPC.0b013e32833de489  1
2010 You JH, Chan WK, Chung PF, Hu M, Tomlinson B. Effects of concomitant therapy with diltiazem on the lipid responses to simvastatin in Chinese subjects. Journal of Clinical Pharmacology. 50: 1151-8. PMID 20150526 DOI: 10.1177/0091270009358082  1
2010 Liu ZK, Hu M, Baum L, Thomas GN, Tomlinson B. Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese. Atherosclerosis. 208: 427-32. PMID 19732897 DOI: 10.1016/j.atherosclerosis.2009.08.013  0.48
2008 Hu M, Tomlinson B. Febuxostat in the management of hyperuricemia and chronic gout: a review. Therapeutics and Clinical Risk Management. 4: 1209-20. PMID 19337428  1
2008 Tomlinson B, Hu M, Lee VW. In vivo assessment of herb-drug interactions: possible utility of a pharmacogenetic approach? Molecular Nutrition & Food Research. 52: 799-809. PMID 18618477 DOI: 10.1002/mnfr.200700454  1
Show low-probability matches.